Indications 

Alvesco is a prescription inhaler indicated for the maintenance treatment of asthma as prophylactic therapy in adult and adolescent patients aged 12 years and older. 

Alvesco belongs to the class of medications known as corticosteroids. It exerts its pharmacological effect by reducing inflammation and irritation in the airways, thus facilitating improved respiratory function. 

Uses and Dosage 

Before using Alvesco and with each prescription refill, carefully read its medication guide and patient information leaflet. For any questions or clarifications, do not hesitate to ask your doctor or pharmacist. 

Alvesco dosage is individualized based on the patient’s medical condition and response to treatment. Typically, it is administered twice a day as prescribed by the doctor. 

Doctors usually initiate treatment with an average dose, which may be increased if symptoms persist after four weeks. Dose reduction may be considered once symptoms are effectively managed. 

To use the Alvesco, follow these steps: 

1. Ensure the inhaler is at room temperature; do not use near heat or open flame. 
2. Remove the cap from the mouthpiece and ensure the canister is fully and firmly inserted. No shaking is required before use. 
3. If using for the first time or after 10 days of non-use, prime by releasing three test sprays away from the face. 
4. Exhale fully as comfortably as you can through your mouth. 
5. Hold the inhaler upright with the mouthpiece down. Position your thumb under the mouthpiece and your index finger on the center of the dose indicator located at the top of the canister. 
6. Place the mouthpiece in your mouth, sealing your lips around it and keeping your tongue below it. 
7. Inhale deeply and slowly through your mouth while pressing down on the dose indicator. As soon as the spray is released, withdraw your index finger. 
8. Remove the inhaler from your mouth and hold your breath for at least ten seconds to facilitate proper medication absorption in your lungs. 
9. After a minimum interval of 1 minute following the first dose, repeat steps 4 to 8 once again to administer the second dose if prescribed by the doctor. 
10. Replace the cap on the mouthpiece. 
11. Rinse your mouth with water and spit it out after each use. Refrain from swallowing the rinse water. 

Clean the inhaler weekly using a clean, dry tissue or cloth. Avoid washing or immersing any part of the inhaler in water. 

For optimal results, use Alvesco regularly at evenly spaced intervals, preferably around the same time each day.  

Do not decrease or increase your dosage or use the inhaler more frequently. Do not discontinue usage of Alvesco without consulting your doctor first. 

Side Effects 

Listed below are the side effects associated with the use of Alvesco. If any of these side effects last or worsen, promptly notify your doctor. 

Common Side Effects 

• Unpleasant taste in the mouth 
• Dry mouth 
• Burning or irritation in the mouth 
• Runny or stuffy nose 
• Sore throat 
• Hoarse voice 
• Mild itching or skin rash 
• Joint pain 
• Back pain 
• Headache 

Serious Side Effects 

• Breathing problems (wheezing, choking) after using this medication 
• Bronchospasm (chest tightness, trouble breathing) 
• Sores or white patches in mouth or throat 
• Vision problems (tunnel or blurred vision) 

• Worsening asthma symptoms 

Call your doctor at once if you experience any of the serious side effects mentioned above. 

Allergic Reactions 

Seek emergency medical attention immediately if you exhibit signs of an allergic reaction to Alvesco, including: 

• Hives 
• Severe abdominal pain 
• Difficulty breathing 
• Face, lips, tongue, or throat swelling 

This list does not contain all the potential side effects of Alvesco. inform your doctor promptly if any unlisted effects are experienced. 

Cautions 

• Alvesco is for inhalation use only.  
• Alvesco is not intended for acute bronchospasm relief.  
• Alvesco is not a bronchodilator and does not address sudden asthma symptoms such as wheezing, coughing, shortness of breath, chest pain, or tightness. Make sure to carry a fast-acting bronchodilator (rescue inhaler) at all times to promptly manage sudden symptoms. 

Before using Alvesco, inform your doctor and pharmacist if you have any known allergies, especially to: 

• Ciclesonide 
• Other corticosteroids such as beclomethasone or fluticasone 
• Any medications 
• Any ingredients present in Alvesco inhaler 

To ensure Alvesco is safe for you, disclose to your physician your medical background, specifically regarding any history of: 

• Tuberculosis 
• Untreated infections caused by fungus or bacteria 
• Certain eye problems such as glaucoma, cataracts, or herpes infection of the eye 
• Liver disease 
• Adrenal gland problems such as adrenal insufficiency 
• Hypothyroidism (underactive thyroid) 
• Osteoporosis (bone loss) 

Alvesco may interact with many products, including aldesleukin, oral corticosteroids (e.g., prednisone, dexamethasone), and mifepristone. To lower the risk of drug interactions, disclose to your physician and pharmacist all the medications you currently use, including prescription and non-prescription drugs, dietary supplements, and herbal products. 

The effectiveness of Alvesco may be affected by medications that impact its removal from the body, including some azole antifungals (e.g., ketoconazole), HIV protease inhibitors (e.g. nelfinavir, ritonavir), and others. 

Alvesco use may conceal signs of infection, increasing the likelihood of acquiring or worsening infections. Refrain from interacting with individuals who have contagious infections like measles, chickenpox, or flu. Consult your doctor if you have been exposed to an infection or need further information. 

Extended use of Alvesco may impact bone strength, particularly in individuals who smoke, have a family history of osteoporosis, or are taking other bone-weakening medications (e.g., phenytoin). Bone density testing may be necessary to determine the need for treatment or prevention.  

Long-term use of Alvesco may also temporarily impede a child’s growth, although uncontrolled asthma can also have the same effect. Regular check-ups with the doctor to monitor the child’s height are recommended. 

The use of Alvesco during pregnancy should be carefully evaluated, weighing the potential benefits against the potential risks to the fetus. 

The transfer of ciclesonide into breast milk and its potential effects on nursing infants is unknown. Consult your doctor prior to use if you are breastfeeding.